DTE vs LEXXW
DTE (DTE) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
DTE currently screens at market cap $0. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the DTE and LEXXW stock pages for the full models.
Not investment advice.